Publications by authors named "Christine Maurer"

Article Synopsis
  • Biotransformation is a crucial area within drug metabolism and pharmacokinetics that evaluates metabolites to ensure drug safety and compliance with regulatory guidelines.
  • Metabolite identification (metID) scientists use various strategies to identify human metabolites early in drug development and assess exposure risks, following guidelines like the Metabolites in Safety Testing (MIST).
  • A survey involving 26 pharmaceutical companies aimed to evaluate the effectiveness of current in vitro metID practices in predicting human metabolites, highlighting the need for a standardized framework and looking toward future advancements.
View Article and Find Full Text PDF
Article Synopsis
  • Hematopoietic progenitor kinase 1 (HPK1) is an important target in immune oncology research because it regulates key signaling pathways in immune cells.
  • Genetic deletion of HPK1 in T cells enhances their response to activation, and HPK1 knockout mice show improved anti-tumor effects.
  • The study details the development of effective HPK1 inhibitors through structure-based drug design, achieving strong potency and increased IL-2 cytokine secretion, which could enhance anti-tumor immune responses.
View Article and Find Full Text PDF

Purpose: To describe the current seating recommendations made by a seating clinic for wheelchair users who presented with a Pressure Injury (PrI) or history of PrI.

Methods: Retrospective review of electronic medical records of 133 adults who used a wheelchair as their primary means of mobility who had a cushion evaluation during which interface pressure mapping data was documented.

Results: Clinicians adjusted 71% of participants' wheelchair cushions, including 49% who received a new cushion, and 37% of participants' wheelchairs.

View Article and Find Full Text PDF

Bruton's tyrosine kinase (BTK) is a member of the Tec kinase family that is expressed in cells of hematopoietic lineage. Evidence has shown that inhibition of BTK has clinical benefit for the treatment of a wide array of autoimmune and inflammatory diseases. Previously we reported the discovery of a novel nicotinamide selectivity pocket (SP) series of potent and selective covalent irreversible BTK inhibitors.

View Article and Find Full Text PDF
Article Synopsis
  • BTK is a key enzyme involved in B-cell disorders, and targeting it has been shown to help treat these conditions.
  • Researchers developed a new series of BTK inhibitors using an imidazo[4,5-b]pyridine design, leading to a promising compound with high potency and selectivity.
  • The lead compound showed strong inhibitory effects in human blood and effective results in a rat model, along with good pharmacokinetic properties.
View Article and Find Full Text PDF

Hit-to-lead optimization is a critical phase in drug discovery. Herein, we report on the fragment-based discovery and optimization of 2-aminopyridine derivatives as a novel lead-like structure for the treatment of the dangerous opportunistic pathogen Pseudomonas aeruginosa. We pursue an innovative treatment strategy by interfering with the Pseudomonas quinolone signal (PQS) quorum sensing (QS) system leading to an abolishment of bacterial pathogenicity.

View Article and Find Full Text PDF

The increasing emergence of antibiotic resistance necessitates the development of anti-infectives with novel modes of action. Targeting bacterial virulence is considered a promising approach to develop novel antibiotics with reduced selection pressure. The extracellular collagenase elastase (LasB) plays a pivotal role in the infection process of Pseudomonas aeruginosa and therefore represents an attractive antivirulence target.

View Article and Find Full Text PDF

Analysis of the genome sequence of the myxobacterium Chondromyces crocatus Cm c5 revealed the presence of numerous cryptic megasynthetase gene clusters, one of which we here assign to two previously unknown chlorinated metabolites by a comparative gene inactivation and secondary metabolomics approach. Structure elucidation of these compounds revealed a unique cyclic depsipeptide skeleton featuring β- and δ-amide bonds of aspartic acid and 3-methyl ornithine moieties, respectively. Insights into their biosynthesis were obtained by targeted gene inactivation and feeding experiments employing isotope-labeled precursors.

View Article and Find Full Text PDF

is a Gram-negative bacterium, which causes opportunistic infections in immuno-compromised individuals. Due to its multiple resistances toward antibiotics, the development of new drugs is required. Interfering with Quorum Sensing (QS), a cell-to-cell communication system, has shown to be highly efficient in reducing pathogenicity.

View Article and Find Full Text PDF

Aim: CsrA is a global post-transcriptional regulator protein affecting mRNA translation and/or stability. Widespread among bacteria, it is essential for their full virulence and thus represents a promising anti-infective drug target. Therefore, we aimed at the discovery of CsrA-RNA interaction inhibitors.

View Article and Find Full Text PDF

Pseudomonas aeruginosa uses quorum sensing (QS) as a cell-to-cell communication system to orchestrate the expression of virulence determinants. The biosynthesis of the important Pseudomonas quinolone signal (PQS) requires the pqsABCDE operon. Here, PqsE acts as a pathway-specific thioesterase, but it also contributes to the regulation of bacterial virulence via an unknown mechanism.

View Article and Find Full Text PDF

Cystic fibrosis (CF) is a genetic disease mainly manifested in the respiratory tract. Pseudomonas aeruginosa (P. aeruginosa) is the most common pathogen identified in cultures of the CF airways, however, its eradication with antibiotics remains challenging as it grows in biofilms that counterwork human immune response and dramatically decrease susceptibility to antibiotics.

View Article and Find Full Text PDF

Increasing antibiotic resistance urgently requires novel therapeutic options to combat bacterial infections. The anti-virulence therapy selectively intervening with pathogenicity without affecting bacterial viability is such a strategy to overcome resistance. We consider the virulence regulator PqsR as an attractive target in the human pathogen Pseudomonas aeruginosa, and recently discovered the first PqsR antagonists, which, however, suffered from poor aqueous solubility.

View Article and Find Full Text PDF

The virulence regulator PqsR of Pseudomonas aeruginosa is considered as an attractive target for attenuating the bacterial pathogenicity without eliciting resistance. However, despite efforts and desires, no promising PqsR antagonist has been discovered thus far. Now, a surprising functionality change of a highly affine PqsR antagonist in P.

View Article and Find Full Text PDF

The appearance of antibiotic resistance requires novel therapeutic strategies. One approach is to selectively attenuate bacterial pathogenicity by interfering with bacterial cell-to-cell communication known as quorum sensing. The PQS quorum sensing system of Pseudomonas aeruginosa employs as signal molecule the Pseudomonas Quinolone Signal (PQS; 2-heptyl-3-hydroxy-4-(1H)-quinolone), a key contributor to virulence and biofilm formation.

View Article and Find Full Text PDF

The human pathogen Pseudomonas aeruginosa employs alkyl quinolones for cell-to-cell communication. The Pseudomonas quinolone signal (PQS) regulates various virulence factors via interaction with the transcriptional regulator PqsR. Therefore, we consider the development of PqsR antagonists a novel strategy to limit the pathogenicity of P.

View Article and Find Full Text PDF

Background: PQS (PseudomonasQuinolone Signal) and its precursor HHQ are signal molecules of the P. aeruginosa quorum sensing system. They explicate their role in mammalian pathogenicity by binding to the receptor PqsR that induces virulence factor production and biofilm formation.

View Article and Find Full Text PDF

2-Heptyl-4-hydroxyquinoline (HHQ) and Pseudomonas quinolone signal (PQS) are involved in the regulation of virulence factor production and biofilm formation in Pseudomonas aeruginosa. PqsD is a key enzyme in the biosynthesis of these signal molecules. Using a ligand-based approach, we have identified the first class of PqsD inhibitors.

View Article and Find Full Text PDF
Article Synopsis
  • Pseudomonas aeruginosa produces a signaling molecule called Pseudomonas quinolone signal through its pqs quorum sensing system, which regulates its virulence factors.
  • Researchers aimed to target the PqsR protein in this system with small molecules to reduce P. aeruginosa's pathogenicity.
  • A potent PqsR antagonist, derived from hydroxamic acid, was developed and showed effectiveness in inhibiting virulence factor production in both E. coli and P. aeruginosa, indicating it could be a promising candidate for future drug design.
View Article and Find Full Text PDF

In recent decades, quantitative transcription assays using bacterial RNA polymerase (RNAP) have been performed under widely diverse experimental conditions. We demonstrate that the template choice can influence the inhibitory potency of RNAP inhibitors. Furthermore, we illustrate that the sigma factor (σ(70)) surprisingly increases the transcription efficiency of templates with nonphysiological nonprokaryotic promoters.

View Article and Find Full Text PDF

The pqs quorum sensing communication system of Pseudomonas aeruginosa controls virulence factor production and is involved in biofilm formation, therefore playing an important role for pathogenicity. In order to attenuate P. aeruginosa pathogenicity, we followed a ligand-based drug design approach and synthesized a series of compounds targeting PqsR, the receptor of the pqs system.

View Article and Find Full Text PDF

Background/objective: Tilt and recline variable position seating systems are most commonly used for pressure relief to decrease potential for skin breakdown. This study provides quantitative information on the magnitudes of loading on the seat and back during phases of tilt, recline, and standing. The objective of this study was to show that the amount of force reduction at the seat would differ across these 3 methods within their respective clinical ranges.

View Article and Find Full Text PDF

Purpose: To present the Participation and Activity Measurement System (PAMS), a system designed to examine activity and participation among people who use wheeled mobility devices.

Methods: Description of PAMS' components and an example of its application among people who use tilt-in-space wheelchairs.

Results: PAMS combines objective and subjective descriptions of mobility-based activities within a person's home and community.

View Article and Find Full Text PDF

Purpose: The goal of this study was to monitor and describe the use of power tilt systems in everyday life. Additionally, tilt measurements were used to determine if participants performed regular pressure relieves.

Methods: Wheelchair occupancy and seat position of 16 fulltime power wheelchair users were monitored regularly for 1-2 weeks.

View Article and Find Full Text PDF